An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
D001780:Blood Coagulation Tests; D002250:Carbon Radioisotopes; D002364:Caseins / Q000096:biosynthesis; D002850:Chromatography, Gel; D005176:Factor XIII / Q000032:analysis / Q000037:antagonists & inhibitors*; D005177:Factor XIII Deficiency / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000302:isolation & purification; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007538:Isoniazid / Q000009:adverse effects*; D008851:Micropore Filters; D008875:Middle Aged; D011700:Putrescine / Q000378:metabolism; D012995:Solubility
D002250:Carbon Radioisotopes; D002364:Caseins; D005340:Fibrinogen; D005176:Factor XIII; D011700:Putrescine; D007538:Isoniazid